scholarly article | Q13442814 |
P2093 | author name string | K Ozawa | |
K Ozaki | |||
K Sato | |||
W J Leonard | |||
I Oh | |||
K Hatanaka | |||
A Meguro | |||
H Matsu | |||
R Tatara | |||
P2860 | cites work | A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice | Q37083674 |
Interleukin-21 is required for the development of type 1 diabetes in NOD mice | Q37163453 | ||
Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation | Q37371294 | ||
Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. | Q42064178 | ||
IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo | Q43459130 | ||
Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans | Q45874932 | ||
An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin | Q71881409 | ||
Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect | Q73785060 | ||
Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation | Q77293917 | ||
IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation | Q77658417 | ||
Overexpression of interleukin 21 induces expansion of hematopoietic progenitor cells | Q79270308 | ||
Long-term T cell fitness and proliferation is driven by AMPK-dependent regulation of reactive oxygen species | Q104282138 | ||
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function | Q24290522 | ||
IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response | Q24307467 | ||
Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells | Q24673146 | ||
Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain | Q24673607 | ||
Interleukin-21 inhibits dendritic cell activation and maturation | Q28191392 | ||
A critical role for IL-21 in regulating immunoglobulin production | Q28215868 | ||
Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6 | Q28288702 | ||
IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways | Q29614839 | ||
Essential autocrine regulation by IL-21 in the generation of inflammatory T cells | Q29616147 | ||
IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells | Q29616148 | ||
Cytokines and immunodeficiency diseases | Q34572193 | ||
The IL-21 receptor augments Th2 effector function and alternative macrophage activation | Q34682153 | ||
Cytokine and cytokine receptor pleiotropy and redundancy | Q34693494 | ||
IL-21 signaling is critical for the development of type I diabetes in the NOD mouse | Q34823699 | ||
Graft-versus-host disease | Q36793622 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 723-729 | |
P577 | publication date | 2009-08-31 | |
P1433 | published in | Bone Marrow Transplantation | Q4941523 |
P1476 | title | IL-21 is critical for GVHD in a mouse model | |
P478 | volume | 45 |
Q35112265 | Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL |
Q34643444 | Altered effector CD4+ T cell function in IL-21R-/- CD4+ T cell-mediated graft-versus-host disease |
Q35669245 | Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes |
Q93031404 | Central Roles of OX40L-OX40 Interaction in the Induction and Progression of Human T Cell-Driven Acute Graft-versus-Host Disease |
Q46779685 | Donor Th17 cells and IL-21 may contribute to the development of chronic graft-versus-host disease after allogeneic transplantation. |
Q26766361 | IL-21 Signaling in Immunity |
Q36923019 | IL-21 accelerates xenogeneic graft-versus-host disease correlated with increased B-cell proliferation |
Q38243870 | IL-21 as a therapeutic target in inflammatory disorders |
Q40656321 | IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. |
Q34587940 | IL2-IL21 gene cluster polymorphism is not associated with allograft function after kidney transplantation. |
Q64110652 | Inflammatory Cytokine Networks in Gastrointestinal Tract Graft vs. Host Disease |
Q34615453 | Interleukin-21 is critically required in autoimmune and allogeneic responses to islet tissue in murine models. |
Q33802076 | Interleukin-21 promotes thymopoiesis recovery following hematopoietic stem cell transplantation |
Q36107077 | Lack of IL-21 signal attenuates graft-versus-leukemia effect in the absence of CD8 T-cells |
Q48290042 | Loss of thymic innate lymphoid cells leads to impaired thymopoiesis in experimental graft-versus-host disease. |
Q37900645 | Regulatory T cells and IL-17-producing cells in graft-versus-host disease |
Q37973866 | The IL-17 differentiation pathway and its role in transplant outcome |
Q88613990 | The Inflammatory Cytokine IL-21 is Expressed by Splenic Neutrophils in Response to Transplantation of Allogeneic Cells |
Q38712496 | Translational opportunities for targeting the Th17 axis in acute graft-vs.-host disease |
Search more.